China Universal China Universal Nasdaq Biotechnology Index ETF (QDII) (SHA:513290)
China · Delayed Price · Currency is CNY 1.761
-0.015 (-0.84%)
At close: Sep 22, 2026
SHA:513290 Holdings Information
SHA:513290 is an equity ETF with a total of 252 individual holdings. The top holdings are Vertex Pharmaceuticals stock at 8.25%, Amgen at 8.00%, Gilead Sciences at 6.99%, Regeneron Pharmaceuticals at 4.56%, and Alnylam Pharmaceuticals at 2.85%.
Total Holdings
252
Top 10 Percentage
41.33%
Asset Class
Equity
ETF Category
Health Care
Assets
n/a
PE Ratio
17.76
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 8.25% |
| 2 | AMGN | Amgen Inc. | 8.00% |
| 3 | GILD | Gilead Sciences, Inc. | 6.99% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 4.56% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.85% |
| 6 | RVMD | Revolution Medicines, Inc. | 2.82% |
| 7 | BIIB | Biogen Inc. | 2.26% |
| 8 | MRNA | Moderna, Inc. | 1.97% |
| 9 | ARGX | argenx SE | 1.82% |
| 10 | ROIV | Roivant Sciences Ltd. | 1.81% |
| 11 | RPRX | Royalty Pharma plc | 1.76% |
| 12 | INSM | Insmed Incorporated | 1.64% |
| 13 | UTHR | United Therapeutics Corporation | 1.63% |
| 14 | INCY | Incyte Corporation | 1.61% |
| 15 | GH | Guardant Health, Inc. | 1.41% |
| 16 | VTRS | Viatris Inc. | 1.31% |
| 17 | NBIX | Neurocrine Biosciences, Inc. | 1.20% |
| 18 | ASND | Ascendis Pharma A/S | 1.16% |
| 19 | MEDP | Medpace Holdings, Inc. | 1.07% |
| 20 | JAZZ | Jazz Pharmaceuticals plc | 1.07% |
| 21 | BBIO | BridgeBio Pharma, Inc. | 1.03% |
| 22 | EXEL | Exelixis, Inc. | 0.97% |
| 23 | IONS | Ionis Pharmaceuticals, Inc. | 0.93% |
| 24 | AXSM | Axsome Therapeutics, Inc. | 0.89% |
| 25 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.88% |
As of Jun 30, 2026